Pfm Health Sciences, LP / AXSM
Pfm Health Sciences, LP’s Axsome Therapeutics Inc. Position
Does Pfm Health Sciences, LP own Axsome Therapeutics Inc. (AXSM)? Yes — 264.3K shares worth $45M (+4.07% of its 13F portfolio) as of Q1 2026, up from 251.6K shares the prior filed quarter.
Position Value
$45M
Q1 2026
Shares
264.3K
% of Portfolio
+4.07%
Quarters Held
16
currently held
Position History AXSM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 264.3K | $45M | +4.07% |
| Q4 2025 | 251.6K | $46M | +4.58% |
| Q3 2025 | 530.3K | $64M | +4.95% |
| Q2 2025 | 483.1K | $50M | +4.29% |
| Q1 2025 | 556.5K | $65M | +4.71% |
| Q4 2024 | 467.4K | $40M | +2.45% |
| Q3 2024 | 467.4K | $42M | +2.38% |
| Q2 2024 | 467.4K | $38M | +1.86% |
| Q1 2024 | 467.4K | $37M | +1.75% |
| Q4 2023 | 467.4K | $37M | +2.23% |
| Q3 2023 | 523.2K | $37M | +1.72% |
| Q2 2023 | 495.6K | $36M | +1.38% |
| Q1 2023 | 606.1K | $37M | +1.65% |
| Q4 2022 | 1.09M | $84M | +3.02% |
| Q3 2022 | 1.66M | $74M | +2.68% |
| Q2 2022 | 1.36M | $52M | +1.99% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Pfm Health Sciences, LP’s full portfolio or all institutional holders of AXSM.